Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
RNA - Avidity Biosciences Inc - Stock Price Chart
TickerRNA [NASD, RUT]
CompanyAvidity Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap3.80BEPS (ttm)-2.90
P/E-EPS this Y3.21%
Forward P/E-EPS next Y-19.22%
PEG-EPS past 5Y-57.60%
P/S375.26EPS next 5Y-7.10%
P/B2.52EPS Q/Q7.77%
Dividend-Sales Q/Q-17.10%
Insider Own9.26%Inst Own101.48%
Insider Trans-5.52%Inst Trans15.38%
Short Float13.81%EarningsNov 07/a
Analyst Recom1.09Target Price67.91
Avg Volume1.35M52W Range13.01 - 56.00
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gallagher Kathleen P.Chief Program OfficerFeb 03 '25Option Exercise16.655,87597,81956,429Feb 05 05:01 PM
Gallagher Kathleen P.Chief Program OfficerFeb 03 '25Sale32.165,875188,91850,554Feb 05 05:01 PM
KATHLEEN GALLAGHEROfficerFeb 03 '25Proposed Sale32.9317,625580,391Feb 03 04:34 PM
LEVIN ARTHUR ADirectorJan 21 '25Sale28.601,87253,53712,958Jan 23 08:17 PM
MacLean Michael FChief Financial OfficerJan 21 '25Sale28.593,28793,985104,655Jan 23 08:15 PM
DCOM - Dime Community Bancshares Inc - Stock Price Chart
TickerDCOM [NASD, RUT]
CompanyDime Community Bancshares Inc
CountryUSA
IndustryBanks - Regional
Market Cap1.35BEPS (ttm)0.58
P/E53.00EPS this Y92.19%
Forward P/E7.83EPS next Y40.70%
PEG-EPS past 5Y-26.63%
P/S2.10EPS next 5Y-
P/B1.05EPS Q/Q-248.45%
Dividend3.28%Sales Q/Q-21.44%
Insider Own5.26%Inst Own75.41%
Insider Trans0.13%Inst Trans4.08%
Short Float5.24%EarningsJan 23/b
Analyst Recom1.00Target Price41.00
Avg Volume338.00K52W Range17.29 - 37.60
Dime Community Bancshares, Inc. is a holding company. It engages in the provision of commercial banking and financial services through its wholly owned subsidiary, Dime Community Bank. The company was founded in 1864 and is headquartered in Hauppauge, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basswood Financial Long Only FDirectorFeb 12 '25Proposed Sale32.8346,9621,541,762Feb 12 06:22 PM
MAHON KENNETH JDirectorFeb 11 '25Sale32.6925,000817,285256,880Feb 12 03:26 PM
MAHON KENNETH JOfficerFeb 11 '25Proposed Sale32.7725,000819,250Feb 11 04:29 PM
BASSWOOD CAPITAL MANAGEMENT, LDirector-by-DeputizationJan 31 '25Buy31.231,04332,5731,043Feb 04 04:15 PM
Fegan MichaelChief Technology & Ops OfficerDec 09 '24Sale35.762,00071,51320,155Dec 10 11:18 AM
ANGI - Angi Inc - Stock Price Chart
TickerANGI [NASD]
CompanyAngi Inc
CountryUSA
IndustryInternet Content & Information
Market Cap820.13MEPS (ttm)0.07
P/E22.09EPS this Y-37.47%
Forward P/E22.19EPS next Y67.85%
PEG0.96EPS past 5Y0.82%
P/S0.69EPS next 5Y22.92%
P/B0.76EPS Q/Q100.00%
Dividend-Sales Q/Q-10.84%
Insider Own87.18%Inst Own9.96%
Insider Trans0.06%Inst Trans-8.93%
Short Float14.07%EarningsFeb 11/a
Analyst Recom2.20Target Price2.91
Avg Volume1.14M52W Range1.49 - 3.10
Angi, Inc. engages in the provision of a digital marketplace for home services. It operates through the following segments: Ads and Leads, Services, Roofing, and International. The Ads and Leads segment provides service professionals the capability to engage with potential customers, including quote and invoicing services, and provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals nationwide for home repair, maintenance and improvement projects. The Services segment includes the provision of services through the Angi platform. Angi fulfills the request through the use of independently established home service providers engaged in a trade, occupation and/or business that customarily provides such services. The Roofing segment includes roof replacement and repair services through its wholly-owned subsidiary, Angi Roofing, LLC. The international segment consists of Europe and Canada. The company was founded on April 13, 2017 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fleischman David EliasChief Product OfficerFeb 06 '25Option Exercise0.00441,6960768,685Feb 07 06:33 PM
LEVIN JOSEPHDirectorJan 13 '25Option Exercise0.005,008,60005,008,600Jan 15 05:51 PM
Orchard GlennChief Growth OfficerJan 01 '25Option Exercise0.0087,500087,500Jan 03 05:29 PM
Carson BaileyChief Operating OfficerDec 01 '24Option Exercise0.0042,1940103,035Dec 03 04:05 PM
Philips JeremyDirectorNov 19 '24Option Exercise0.008,342081,126Nov 21 05:03 PM
WAT - Waters Corp - Stock Price Chart
TickerWAT [NYSE, S&P 500]
CompanyWaters Corp
CountryUSA
IndustryDiagnostics & Research
Market Cap22.68BEPS (ttm)10.71
P/E35.64EPS this Y8.19%
Forward P/E27.11EPS next Y9.80%
PEG3.80EPS past 5Y4.27%
P/S7.67EPS next 5Y9.37%
P/B14.14EPS Q/Q6.44%
Dividend-Sales Q/Q6.50%
Insider Own0.36%Inst Own96.34%
Insider Trans0.00%Inst Trans-1.66%
Short Float2.71%EarningsFeb 12/b
Analyst Recom2.75Target Price403.00
Avg Volume474.69K52W Range279.24 - 423.56
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FEARON RICHARD HDirectorMay 28 '24Buy332.901,000332,9001,653May 29 11:23 AM
KUEBLER CHRISTOPHER ADirectorMay 15 '24Option Exercise113.884,000455,52018,716May 16 10:55 AM
KUEBLER CHRISTOPHER ADirectorMay 15 '24Sale361.644,0001,446,56014,716May 16 10:55 AM
BADDOUR LINDADirectorMar 13 '24Sale355.54500177,7702,250Mar 14 11:08 AM
ELTX - Elicio Therapeutics Inc - Stock Price Chart
TickerELTX [NASD]
CompanyElicio Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap90.64MEPS (ttm)-4.11
P/E-EPS this Y41.59%
Forward P/E-EPS next Y27.68%
PEG-EPS past 5Y3.87%
P/S-EPS next 5Y29.88%
P/B-EPS Q/Q-9.00%
Dividend-Sales Q/Q-
Insider Own30.12%Inst Own9.82%
Insider Trans0.00%Inst Trans-6.13%
Short Float1.73%EarningsNov 13/a
Analyst Recom2.00Target Price9.00
Avg Volume40.01K52W Range3.34 - 11.45
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeMuth PeterChief Scientific OfficerDec 16 '24Option Exercise4.413811,680381Dec 18 04:51 PM
EVAX - Evaxion Biotech A/S ADR - Stock Price Chart
TickerEVAX [NASD]
CompanyEvaxion Biotech A/S ADR
CountryDenmark
IndustryBiotechnology
Market Cap3.07MEPS (ttm)-14.54
P/E-EPS this Y89.93%
Forward P/E-EPS next Y63.64%
PEG-EPS past 5Y-18.88%
P/S0.93EPS next 5Y-
P/B2.26EPS Q/Q82.80%
Dividend-Sales Q/Q-
Insider Own-Inst Own9.92%
Insider Trans-Inst Trans-
Short Float-EarningsOct 31/b
Analyst Recom1.00Target Price31.92
Avg Volume2.34M52W Range2.22 - 23.70
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Moller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
FFWM - First Foundation Inc - Stock Price Chart
TickerFFWM [NYSE, RUT]
CompanyFirst Foundation Inc
CountryUSA
IndustryBanks - Regional
Market Cap421.71MEPS (ttm)-1.33
P/E-EPS this Y288.32%
Forward P/E11.98EPS next Y116.46%
PEG-EPS past 5Y-
P/S0.64EPS next 5Y-
P/B0.44EPS Q/Q-480.71%
Dividend0.26%Sales Q/Q3.53%
Insider Own12.44%Inst Own76.53%
Insider Trans0.00%Inst Trans64.22%
Short Float3.11%EarningsJan 30/b
Analyst Recom2.50Target Price7.33
Avg Volume485.11K52W Range4.66 - 8.56
First Foundation, Inc. is a bank holding, which engages in the provision of a comprehensive platform of financial services to individuals, businesses, and organizations. It operates through the following segments: Banking, Wealth Management, and Other. The company was founded by John Avak Hakopian and Ulrich Emanuel Keller, Jr. in 1990 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KAVANAUGH SCOTT FAffiliateDec 18 '24Proposed Sale6.58636,1604,182,752Dec 18 04:16 PM
Britton JamesChief Financial OfficerAug 29 '24Option Exercise6.944,00027,7604,000Sep 03 12:48 PM
Nuno Hugo J.Chief Banking OfficerFeb 29 '24Option Exercise7.931,1248,91313,048Mar 04 01:06 PM
Naghibi Christopher M.Chief Operating OfficerFeb 29 '24Option Exercise7.931,39411,0547,148Mar 04 01:03 PM
HAKOPIAN JOHNPresident, FFAFeb 29 '24Option Exercise7.936525,17036,390Mar 04 12:57 PM
HROW - Harrow Inc - Stock Price Chart
TickerHROW [NASD, RUT]
CompanyHarrow Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.07BEPS (ttm)-0.94
P/E-EPS this Y10.93%
Forward P/E77.16EPS next Y158.08%
PEG-EPS past 5Y-
P/S6.30EPS next 5Y-
P/B18.51EPS Q/Q7.80%
Dividend-Sales Q/Q43.75%
Insider Own13.67%Inst Own58.61%
Insider Trans-0.41%Inst Trans8.20%
Short Float9.67%EarningsNov 13/a
Analyst Recom1.00Target Price57.88
Avg Volume427.20K52W Range9.30 - 59.23
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Opaleye Management Inc.10% OwnerJan 22 '25Sale35.5920,000711,814155,000Jan 24 09:29 PM
SAHAREK JOHN P.CEO of ImprimisRxSep 11 '24Option Exercise7.3790,000663,300344,803Sep 13 05:26 PM
Opaleye Management Inc.10% OwnerApr 25 '24Buy9.9720,000199,4003,815,000Apr 25 05:19 PM
Opaleye Management Inc.10% OwnerApr 23 '24Buy10.2911,715120,5473,786,715Apr 24 04:40 PM
Opaleye Management Inc.10% OwnerApr 24 '24Buy10.158,28584,0933,795,000Apr 24 04:40 PM
EQNR - Equinor ASA ADR - Stock Price Chart
TickerEQNR [NYSE]
CompanyEquinor ASA ADR
CountryNorway
IndustryOil & Gas Integrated
Market Cap63.63BEPS (ttm)3.11
P/E7.48EPS this Y1.07%
Forward P/E7.07EPS next Y1.19%
PEG13.60EPS past 5Y41.31%
P/S0.62EPS next 5Y0.55%
P/B1.43EPS Q/Q-17.11%
Dividend6.58%Sales Q/Q-8.00%
Insider Own0.00%Inst Own2.50%
Insider Trans-Inst Trans-2.22%
Short Float0.50%EarningsFeb 05/b
Analyst Recom1.78Target Price29.49
Avg Volume3.72M52W Range21.83 - 28.53
Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway, Exploration and Production International, Exploration and Production USA, Marketing, Midstream, and Processing, Renewables, and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Exploration and Production USA segment covers both onshore and offshore exploration, development, and Production of oil and gas in the USA. The Marketing, Midstream, and Processing segment markets and trades of crude oil and condensate, natural gas, NGL and refined products. The Renewables segment focuses on offshore wind, and integrated solutions for onshore renewables. The Other segment includes projects, drilling and procurement, the business area technology, digital and innovation, and corporate staffs and support functions. The company was founded on September 18, 1972, and is headquartered in Stavanger, Norway.
CRKN - Crown ElectroKinetics Corp - Stock Price Chart
TickerCRKN [NASD]
CompanyCrown ElectroKinetics Corp
CountryUSA
IndustrySpecialty Chemicals
Market Cap8.23MEPS (ttm)-12383.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y7.46%
P/S0.61EPS next 5Y-
P/B0.02EPS Q/Q99.11%
Dividend-Sales Q/Q-
Insider Own0.06%Inst Own0.56%
Insider Trans0.00%Inst Trans-
Short Float11.51%EarningsNov 14/b
Analyst Recom3.00Target Price2025000.00
Avg Volume434.79K52W Range5.42 - 13500.00
Crown ElectroKinetics Corp. engages in the commercialization of electro kinetic technology for use in the smart glass market. It develops and sells optical switching film that can be embedded between glass or applied to the surface of glass or other rigid substrates such as acrylic, to electronically control opacity. The company was founded by Douglas B. Croxall and Timothy Koch on April 20, 2015 and is headquartered in Corvallis, OR.
110121314151617181920